BARCLAYS PLC

Position in FOLD — AMICUS THERAPEUTICS, INC.

CIK 312069 LONDON, X0

Back to FOLD Full portfolio

Position in FOLD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$19,354,449

+$3,197,191 QoQ

Shares Held

1,338,482

+18.0% QoQ

Ownership

0.426%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in FOLD Over Time

Shares Held

Position Value (USD)

Derivatives in FOLD

reported options exposure · as of Sep 30, 2025

CallValue

CallShares

PutValue

$898,320

PutShares

114,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. FOLD ranks #18 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

All Filings in FOLD

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,354,449	1,338,482	+18.0%	Shares	Defined	2026-05-15
2025-12-31	$16,157,258	1,134,639	+895.3%	Shares	Sole	2026-02-13
2025-09-30	$898,320	114,000	-88.2%	Put	Sole	2026-03-31
2025-09-30	$7,639,831	969,522	+2892.4%	Shares	Sole	2026-03-31
2025-06-30	$185,652	32,400	-71.6%	Call	Sole	2026-02-27
2025-06-30	$653,220	114,000	-90.4%	Put	Sole	2026-02-27
2025-06-30	$6,777,069	1,182,735	+707.9%	Shares	Sole	2026-02-27
2025-03-31	$1,194,624	146,400	-77.0%	Put	Sole	2026-03-17
2025-03-31	$5,190,558	636,098	+1863.3%	Shares	Sole	2026-03-17
2025-03-31	$264,384	32,400	-71.6%	Call	Sole	2026-03-17
2024-12-31	$1,073,880	114,000	-82.8%	Put	Sole	2026-03-19
2024-12-31	$6,261,095	664,660	+5.2%	Shares	Sole	2026-03-19
2024-09-30	$6,746,608	631,705	+454.1%	Shares	Sole	2026-03-31
2024-09-30	$1,217,520	114,000	0.0%	Put	Sole	2026-03-31
2024-06-30	$1,130,880	114,000	-74.5%	Call	Sole	2026-03-23
2024-06-30	$4,428,197	446,391	+426.4%	Shares	Sole	2026-03-23
2024-03-31	$998,944	84,800	-75.7%	Put	Sole	2026-03-24
2024-03-31	$4,110,476	348,937	-52.1%	Shares	Sole	2026-03-24
2023-12-31	$10,327,127	727,775	+76.5%	Shares	Sole	2026-03-24
2023-09-30	$5,015,221	412,436	+1.8%	Shares	Sole	2026-03-26
2023-06-30	$5,091,069	405,340	-11.3%	Shares	Sole	2026-03-27
2023-03-31	$5,069,793	457,150	+8.4%	Shares	Sole	2026-03-30
2022-12-31	$5,150,422	421,820	+4.0%	Shares	Sole	2026-03-30
2022-09-30	$4,233,638	405,521	+2111.6%	Shares	Sole	2022-11-03
2022-06-30	$196,928	18,336	-82.9%	Shares	Sole	2022-08-12
2022-03-31	$1,015,354	107,218	-67.1%	Shares	Sole	2022-05-16
2021-12-31	$3,768,291	326,259	-27.8%	Shares	Sole	2022-02-23
2021-09-30	$4,317,917	452,138	+102.0%	Shares	Sole	2021-11-09
2021-06-30	$2,157,498	223,807	-48.2%	Shares	Sole	2021-08-13
2021-03-31	$4,265,719	431,753	+143817.7%	Shares	Sole	2021-05-13
2021-03-31	$2,964	300	-99.9%	Call	Sole	2021-05-13
2020-12-31	$6,384,385	276,500	+36.9%	Put	Sole	2021-02-11
2020-12-31	$4,662,815	201,941	-54.2%	Shares	Sole	2021-02-11
2020-09-30	$6,221,666	440,628	-8.1%	Shares	Sole	2020-11-12
2020-06-30	$7,229,125	479,385	-14.6%	Shares	Sole	2020-08-12
2020-03-31	$5,186,790	561,341	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.